CME Breakfast Symposium: The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

Moderator: Sanjiv S. Agarwala, MD
Supported by an educational grant from Bristol-Myers Squibb
7:30 am – 7:40 am
Introduction and Pretest
Sanjiv S. Agarwala, MD
7:40 am – 8:00 am
Checkpoint Inhibitors in Metastatic Melanoma – Focus on Long-term Outcomes
Sanjiv S. Agarwala, MD
8:00 am – 8:20 am
Checkpoint Inhibitors in Brain Metastases: Implications for Standard of Care
Hussein A. Tawbi, MD, PhD
8:20 am – 8:25 am
8:25 am – 8:30 am
Question and Answer


8:30 am – 8:35 am
Opening Remarks

Community Oncology: How to Keep Up in a Fast-paced Field

Program Chairs: Sanjiv S. Agarwala, MD; Edward S. Kim, MD, FACP; David L. Porter, MD
8:35 am – 8:55 am
We’ll kick off the meeting with a preview of what’s in store for the weekend and what it means to the entire cancer team. Our focus will be on topics that will have direct relevance for the practicing oncologist. We’ll cover areas that are rapidly changing with molecular testing for diagnosis, prognosis and monitoring as well as highlight the incredible advances and improvements in this new environment of targeted and immunotherapies.

Lung Cancer

Moderator: Edward S. Kim, MD, FACP
8:56 am – 8:59 am
9:00 am – 9:20 am
Treatment Approaches for Lung Cancer: A Model for Precision Medicine
Edward S. Kim, MD, FACP
9:21 am – 9:41 am
Front-line Treatment of Lung Cancer
Philip D. Bonomi, MD
9:42 am – 10:02 am
Salvage Treatment Options
Benjamin P. Levy, MD
10:03 am – 10:23 am
Updates in Locally Advanced Disease
Melissa L. Johnson, MD
10:24 am – 10:44 am
Targeted Therapy and Biomarker Selection
Neal E. Ready, MD, PhD
10:45 am – 10:55 am
Discussion and Posttest

Exhibit Hall Break

10:55 am – 11:25 am
Refreshments and Networking

Case Studies in Lung Cancer

Moderator: Edward S. Kim, MD, FACP
11:25 am – 11:28 am
11:29 am – 11:44 am
Molecular Tumor Board: Review of a Genomic Report and Treatment Options
Melissa L. Johnson, MD
11:45 am – 12:00 pm
First Line Chemotherapy/Immunotherapy in a Patient with Brain Metastases
Philip D. Bonomi, MD
12:01 pm – 12:16 pm
Blood Based Biomarker Testing in Lung Cancer
Neal E. Ready, MD, PhD
12:17 pm – 12:27 pm
Panel Discussion
Philip D. Bonomi, MD; Melissa L. Johnson, MD; Benjamin P. Levy, MD; Neal E. Ready, MD, PhD
12:28 pm – 12:30 pm
12:30 pm – 12:35 pm

Industry Expert Theater Lunch**

12:35 pm – 1:35 pm
A Treatment Option for Patients With Melanoma in the Advanced and Adjuvant Settings
Sponsored by Merck & Co., Inc.
**This portion of the meeting is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by HemOnc Today New York 2019 or its accredited provider.
1:35 pm – 1:40 pm


Moderator: Sanjiv S. Agarwala, MD
1:40 pm – 1:43 pm
1:44 pm – 2:04 pm
Early Detection of Melanoma: From Genetic Testing to Technology-driven Educational Campaigns
Sancy Leachman, MD, PhD
2:05 pm – 2:25 pm
Curing Melanoma with Adjuvant Therapy: Are We There Yet?
Sanjiv S. Agarwala, MD
2:26 pm – 2:46 pm
Finding the Right Partner for Anti PD-1: Where Are We Now?
Steven J. O’Day, MD
2:47 pm – 3:07 pm
Treatment Algorithm for Newly Diagnosed Metastatic Melanoma
Nikhil I. Khushalani, MD
3:08 pm – 3:30 pm
Discussion and Posttest

Exhibit Hall Break

3:30 pm – 4:00 pm
Refreshments and Networking

Case Studies in Melanoma

Moderator: Merrick I. Ross, MD
4:00 pm – 4:03 pm
4:04 pm – 4:14 pm
Patient with One Positive Sentinel Lymph Node on Staging
4:15 pm – 4:25 pm
Metastatic Melanoma BRAF-positive Disease
4:26 pm – 4:36 pm
Metastatic Melanoma BRAF Wild-type Disease
4:37 pm – 4:47 pm
Case To Be Announced
4:48 pm – 5:00 pm
Discussion and Posttest

Meet the Faculty Reception*

5:00 pm – 6:00 pm
Take this opportunity to network one-on-one with faculty and colleagues while light appetizers and drinks are served.
*This portion of the meeting is not approved for AMA PRA Category 1 Credit(s)™.